AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Nelson, SJ Charlett, A Orr, HJ Barker, RM Neal, KR Taylor, C Monk, PN Evans, MR Stuart, JM
Citation: Sj. Nelson et al., Risk factors for meningococcal disease in university halls of residence, EPIDEM INFE, 126(2), 2001, pp. 211-217

Authors: Woodruff, TM Strachan, AJ Sanderson, SD Monk, PN Wong, AK Fairlie, DP Taylor, SM
Citation: Tm. Woodruff et al., Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes, INFLAMMATIO, 25(3), 2001, pp. 171-177

Authors: Cain, SA Williams, DM Harris, V Monk, PN
Citation: Sa. Cain et al., Selection of novel ligands from a whole-molecule randomly mutated C5a library, PROTEIN ENG, 14(3), 2001, pp. 189-193

Authors: Cain, SA Coughlan, T Monk, PN
Citation: Sa. Cain et al., Mapping the ligand-binding site on the C5a receptor: Arginine(74) of C5a contacts aspartate(282) of the C5a receptor, BIOCHEM, 40(46), 2001, pp. 14047-14052

Authors: Cain, SA Woodruff, TM Taylor, SM Fairlie, DP Sanderson, SD Monk, PN
Citation: Sa. Cain et al., Modulation of ligand selectivity by mutation of the first extracellular loop of the human C5a receptor, BIOCH PHARM, 61(12), 2001, pp. 1571-1579

Authors: Higginbottom, A Quinn, ER Kuo, CC Flint, M Wilson, LH Bianchi, E Nicosia, A Monk, PN McKeating, JA Levy, S
Citation: A. Higginbottom et al., Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2, J VIROLOGY, 74(8), 2000, pp. 3642-3649

Authors: Cain, SA Ratcliffe, CF Williams, DM Harris, V Monk, PN
Citation: Sa. Cain et al., Analysis of receptor/ligand interactions using whole-molecule randomly-mutated ligand libraries, J IMMUNOL M, 245(1-2), 2000, pp. 139-145

Authors: Higginbottom, A Wilkinson, I McCullough, B Lanza, F Azorsa, DO Partridge, LJ Monk, PN
Citation: A. Higginbottom et al., Antibody cross-linking of human CD9 and the high-affinity immunoglobulin Ereceptor stimulates secretion from transfected rat basophilic leukaemia cells, IMMUNOLOGY, 99(4), 2000, pp. 546-552

Authors: Vogen, SM Finch, AM Wadi, SK Thatcher, J Monk, PN Taylor, SM Sanderson, SD
Citation: Sm. Vogen et al., The influence of Lys68 in decapeptide agonists of C5a on C5a receptor binding, activation and selectivity, J PEPT RES, 53(1), 1999, pp. 8-17

Authors: Murdoch, C Monk, PN Finn, A
Citation: C. Murdoch et al., CXC chemokine receptor expression on human endothelial cells, CYTOKINE, 11(9), 1999, pp. 704-712

Authors: Murdoch, C Monk, PN Finn, A
Citation: C. Murdoch et al., Functional expression of chemokine receptor CXCR4 on human epithelial cells, IMMUNOLOGY, 98(1), 1999, pp. 36-41

Authors: Paczkowski, NJ Finch, AM Whitmore, JB Short, AJ Wong, AK Monk, PN Cain, SA Fairlie, DP Taylor, SM
Citation: Nj. Paczkowski et al., Pharmacological characterization of antagonists of the C5a receptor, BR J PHARM, 128(7), 1999, pp. 1461-1466

Authors: Crass, T Bautsch, W Cain, SA Pease, JE Monk, PN
Citation: T. Crass et al., Receptor activation by human C5a des Arg(74) but not intact C5a is dependent on an interaction between Glu(199) of the receptor and Lys(68) of the ligand, BIOCHEM, 38(30), 1999, pp. 9712-9717
Risultati: 1-13 |